Gastrointestinal Cancer

Latest News

MEV01 trial results show that the test achieved an 86% early-stage sensitivity and 88% specificity in surveillance of HCC among patients with cirrhosis.

FDA Grants EvoLiver Biopsy Test Breakthrough Device Designation for HCC

April 23rd 2025

MEV01 trial results show that the test achieved an 86% early-stage sensitivity and 88% specificity in surveillance of HCC among patients with cirrhosis.

Fruquintinib Combo Exhibits Manageable Safety Profile in Pretreated mCRC

By Tim Cortese

April 22nd 2025

3 Things You Should Know About Advances in Gastroesophageal Adenocarcinoma Therapy

By ONCOLOGY Staff

April 17th 2025

Although the overall incidence of colorectal adenocarcinoma is decreasing, the reduction is primarily associated with patients 55 years and older.

Pancreatic/Colorectal Adenocarcinoma Rates Have Increased in Young Adults

By Roman Fabbricatore

April 15th 2025

Robot-Assisted Esophagectomy Achieves “Best Outcome Data” in Study

By Tim Cortese

April 14th 2025

Latest CME Events & Activities

Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®

BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC

Go To PER in Chicago

May 30, 2025 - June 3, 2025

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers

...

51 52 53 54 55

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777